Lubbock, TX, United States of America

Phat Tran

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Phat Tran: Innovator in Modified Tetracycline Treatments

Introduction

Phat Tran is a notable inventor based in Lubbock, Texas. He has made significant contributions to the field of medicine, particularly in the treatment of alcohol use disorder and other inflammatory conditions. With two patents to his name, Tran's work is paving the way for innovative therapeutic approaches.

Latest Patents

Phat Tran's latest patents focus on a modified tetracycline for the treatment of alcohol use disorder, pain, and other disorders involving potential inflammatory processes. The method involves providing a subject with an effective amount of a modified tetracycline or its derivative to ameliorate or eliminate conditions such as Alcohol Use Disorder (AUD), Substance Use Disorder (SUD), tobacco use, pain, or proinflammatory disorders. The modified tetracycline has reduced binding to a microbial ribosome and includes specific chemical modifications, where R1 is acetyl, R2 is OH or acetyl, R3 is acetyl, R4 is H or acetyl, and R5 is acetyl.

Career Highlights

Phat Tran is affiliated with the Texas Tech University System, where he continues to engage in research and development of innovative treatments. His work is characterized by a commitment to addressing complex health issues through scientific inquiry and invention.

Collaborations

Some of his notable coworkers include Susan E. Bergeson and Peter Syapin, who contribute to the collaborative environment that fosters innovation at Texas Tech University System.

Conclusion

Phat Tran's contributions to the field of medicine through his innovative patents highlight the importance of research in developing effective treatments for complex disorders. His work exemplifies the potential of modified tetracycline in addressing significant health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…